
|Articles|July 1, 2007
Lightening up: Other options
National report - With no indication when the Food and Drug Administration (FDA) will decide on its proposed rule essentially banning all hydroquinone products that have not undergone the new drug approval process, dermatologists and patients are seeking alternatives.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
5











